Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -360,367 | -412,830 | -226,429 | -283,226 | -67,792 |
| Depreciation Amortization | 22,351 | 15,697 | 7,993 | 3,809 | 1,721 |
| Accounts receivable | -7,375 | -9,126 | N/A | N/A | N/A |
| Other Working Capital | 14,646 | 8,439 | 21,345 | 700 | 178 |
| Other Operating Activity | 65,343 | 55,379 | 34,189 | 190,979 | 37,887 |
| Operating Cash Flow | $-265,402 | $-342,441 | $-162,902 | $-87,738 | $-28,006 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,392 | -5,079 | -5,935 | -4,643 | -1,629 |
| Purchase Of Investment | -231,107 | -511,521 | -640,709 | -204,344 | -125,825 |
| Sale Of Investment | 529,274 | 456,465 | 257,172 | 112,402 | 57,241 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1 |
| Investing Cash Flow | $287,775 | $-60,135 | $-389,472 | $-96,585 | $-70,214 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 447,573 | N/A | N/A | N/A |
| Common Stock Issued | 2,838 | 5,173 | 565,469 | 190,983 | 66,071 |
| Other Financing Activity | 0 | -38,364 | 0 | 0 | 1 |
| Financing Cash Flow | $2,838 | $414,382 | $565,469 | $190,983 | $66,072 |
| Exchange Rate Effect | 1,127 | -873 | -376 | N/A | 0 |
| Beginning Cash Position | 43,675 | 32,742 | 20,023 | 13,363 | 45,512 |
| End Cash Position | 70,013 | 43,675 | 32,742 | 20,023 | 13,363 |
| Net Cash Flow | $26,338 | $10,933 | $12,719 | $6,660 | $-32,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | -265,402 | -342,441 | -162,902 | -87,738 | -28,006 |
| Capital Expenditure | -10,392 | -5,079 | -5,935 | -4,643 | -1,629 |
| Free Cash Flow | -275,794 | -347,520 | -168,837 | -92,381 | -29,635 |